Zoekresultaten - 4 results
Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016–2020)
Lyme borreliosis Persisting non-specific symptoms Post-treatment Lyme disease syndrome Abstract: Background Patients with Lyme borreliosis (LB) may report persisting non-specific symptoms such as ...
Lyme borreliosis in Belgium: a cost-of-illness analysis
erythema migrans (EM) or disseminated/late LB, including patients who developed post-treatment Lyme disease syndrome (PTLDS). Direct medical, direct non-medical (transportation & paid help) and indirect ...
Tick-borne diseases in Belgium: The incidence and economic burden of Lyme borreliosis and the occurrence of other tick-borne infections
Post-treatment Lyme disease syndrome Tick-borne pathogens Abstract: Lyme borreliosis (LB) is the most prevalent tick-borne disease in Europe. The most common clinical manifestation is an erythema migrans, a red ...
The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium.
aspecific symptoms for six months or more (e.g. fatigue, widespread musculoskeletal pain, cognitive difficulties), a syndrome now named “post-treatment Lyme disease syndrome” (PTLDS). Controversy exists on ...